Daiichi Sankyo (OTCMKTS:DSNKY) Releases FY 2024 Earnings Guidance

Daiichi Sankyo (OTCMKTS:DSNKY) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.800-0.800 for the period. The company issued revenue guidance of $12.3 billion-$12.3 billion.

Daiichi Sankyo Trading Down 1.4 %

Shares of OTCMKTS DSNKY opened at $32.13 on Friday. The company has a 50-day moving average price of $35.04 and a 200-day moving average price of $35.38. Daiichi Sankyo has a 1 year low of $25.26 and a 1 year high of $42.48.

About Daiichi Sankyo

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.